Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Status:
Completed
Trial end date:
2017-10-10
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of mirtazapine in reducing anxiety in children
with autistic disorder, Asperger's disorder and Pervasive Developmental Disorder.